Drug-eluting balloon: is it useful? [PDF]
The Egyptian Heart Journal, 2020 Background Coronary artery disease is one of the major issues in the medical world around the globe. The prevalence tends to increase. The use of coronary intervention is one of the ways often used in the management of coronary artery disease due to its ...
Sidhi Laksono +2 more
doaj +3 more sources
Research progress of drug eluting balloon in arterial circulatory system [PDF]
Frontiers in Cardiovascular MedicineThe arterial circulatory system diseases are common in clinical practice, and their treatment options have been of great interest due to their high morbidity and mortality.
Keji Lu +13 more
doaj +3 more sources
A Multilayer Functionalized Drug-Eluting Balloon for Treatment of Coronary Artery Disease. [PDF]
Pharmaceutics, 2021 Drug-eluting balloons (DEBs) have been mostly exploited as an interventional remedy for treating atherosclerosis instead of cardiovascular stents. However, the therapeutic efficacy of DEB is limited due to their low drug delivery capability to the ...
Lee HI +5 more
europepmc +2 more sources
Drug-eluting balloon treatment in femoropopliteal in-stent restenosis of different lengths. [PDF]
Turk Gogus Kalp Damar Cerrahisi Derg, 2020 Background In this study, we present one-year results of drugeluting balloon treatment of femoropopliteal in-stent restenosis. Methods A total of 62 patients (48 males, 14 females; mean age 64.2±9.1 years; range, 54 to 81 years) who underwent ...
Özpak B, Çayır MÇ.
europepmc +2 more sources
A drug-eluting Balloon for the trEatment of coronarY bifurcatiON lesions in the side branch: a prospective multicenter ranDomized (BEYOND) clinical trial in China. [PDF]
Chin Med J (Engl), 2020 Supplemental Digital Content is available in the ...
Jing QM +15 more
europepmc +2 more sources
Paclitaxel-coated drug-eluting balloon for pulmonary vein stenosis after repair of total anomalous pulmonary venous return with asplenia. [PDF]
J Cardiol Cases, 2020 We used a paclitaxel-coated drug-eluting balloon (DEB) for pulmonary vein stenosis (PVS) after repair of total anomalous pulmonary venous return with asplenia.
Ono H +7 more
europepmc +2 more sources
Microneedle drug eluting balloon for enhanced drug delivery to vascular tissue
Journal of Controlled Release, 2020 High rates of restenosis and neointimal formation have driven increasing interest in the application of drug eluting balloons (DEB) as counteractive measures for intraluminal drug delivery.
Da Som Yang +2 more
exaly +2 more sources
Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis. [PDF]
Coron Artery Dis, 2019 Objective Approximately, 10–20% of patients with drug eluting stent (DES) in-stent restenosis (ISR) will develop recurrent ISR; yet, the optimal management of recurrent DES-ISR is unknown.
Wang G +5 more
europepmc +2 more sources
Journal of the American College of Cardiology, 2019 BACKGROUND Drug-eluting technologies improve 12-month angiographic results of femoropopliteal (FP) interventions, but few data on the comparison between drug-coated balloons (DCBs) and drug-eluting stents (DES) are available. OBJECTIVES The aim of this
F. Liistro +9 more
semanticscholar +2 more sources
Drug-eluting balloon catheters for lower limb peripheral arterial disease: the evidence to date
Vascular Health and Risk Management, 2016 Mohamed Barkat,1 Francesco Torella,1 George A Antoniou2 1Liverpool Vascular and Endovascular Service, Royal Liverpool University Hospital, Liverpool, 2Department of Vascular and Endovascular Surgery, The Royal Oldham Hospital, Pennine Acute Hospitals NHS
Barkat M, Torella F, Antoniou GA
doaj +1 more source